Phreesia, Inc. (NYSE:PHR) Short Interest Update

Phreesia, Inc. (NYSE:PHR) was the recipient of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 2,730,000 shares, a decline of 14.7% from the November 30th total of 3,200,000 shares. Based on an average daily volume of 406,000 shares, the short-interest ratio is currently 6.7 days.

Insider Buying and Selling at Phreesia

In related news, SVP David Linetsky sold 2,011 shares of the company’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total value of $42,291.33. Following the transaction, the senior vice president now directly owns 201,307 shares in the company, valued at approximately $4,233,486.21. This represents a 0.99 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, General Counsel Allison C. Hoffman sold 1,212 shares of the business’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total transaction of $25,488.36. Following the completion of the sale, the general counsel now directly owns 119,791 shares of the company’s stock, valued at $2,519,204.73. This represents a 1.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 90,342 shares of company stock worth $2,041,225 over the last ninety days. Insiders own 5.80% of the company’s stock.

Hedge Funds Weigh In On Phreesia

Several institutional investors have recently added to or reduced their stakes in the business. Franklin Resources Inc. lifted its position in shares of Phreesia by 3.0% during the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after acquiring an additional 42,973 shares during the period. Geode Capital Management LLC raised its holdings in shares of Phreesia by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after purchasing an additional 55,934 shares during the period. M&T Bank Corp boosted its position in shares of Phreesia by 4.6% during the 3rd quarter. M&T Bank Corp now owns 35,127 shares of the company’s stock worth $801,000 after purchasing an additional 1,535 shares in the last quarter. Barclays PLC grew its stake in shares of Phreesia by 83.6% in the 3rd quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after buying an additional 43,225 shares during the period. Finally, XTX Topco Ltd acquired a new position in Phreesia during the 3rd quarter worth approximately $247,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Phreesia Trading Down 2.8 %

PHR stock traded down $0.72 during trading on Tuesday, hitting $25.01. The company had a trading volume of 84,480 shares, compared to its average volume of 446,422. The company has a current ratio of 1.74, a quick ratio of 1.77 and a debt-to-equity ratio of 0.04. Phreesia has a one year low of $17.07 and a one year high of $29.16. The business has a 50-day moving average of $21.30 and a 200-day moving average of $22.19. The stock has a market cap of $1.45 billion, a PE ratio of -17.01 and a beta of 0.98.

Phreesia (NYSE:PHR) last announced its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same quarter last year, the firm earned ($0.58) earnings per share. Phreesia’s quarterly revenue was up 16.6% on a year-over-year basis. Research analysts predict that Phreesia will post -1.16 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. Truist Financial upped their target price on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. JPMorgan Chase & Co. lifted their price target on Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Monday, September 9th. DA Davidson reaffirmed a “buy” rating and issued a $32.00 price objective on shares of Phreesia in a research note on Thursday, September 5th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $23.00 price objective on shares of Phreesia in a research report on Friday, September 27th. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $29.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.